Wendye Robbins
CIK 1791244 · last filed 2025-04-02
Wendye Robbins is a corporate insider who has filed 30 SEC Form 4 insider transactions across 1 company since 2019. The most recent filing, for RAPT, was dated Apr 2, 2025. Across all open-market trades the lifetime net is +$602.0K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
30
$602.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RAPT Therapeutics, Inc. (RAPT) Delisted | Director | 20,400 | $58.01 | $1.18M | $602.0K | 30 | 2025-04-02 |
Recent Filings
30 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-04-02 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-23 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-04-01 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-25 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-04-10 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-03-15 | RAPT Therapeutics, Inc. (RAPT) Delisted | Buy (P) | +5,000 | $97.6K | EDGAR |
| 2022-05-26 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-12 | RAPT Therapeutics, Inc. (RAPT) Delisted | Buy (P) | +7,000 | $77.3K | EDGAR |
| 2022-04-04 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-10-19 | RAPT Therapeutics, Inc. (RAPT) Delisted | Buy (P) | +500 | $15.3K | EDGAR |